Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Solubilizers
Film Formers & Plasticizers
Thickeners and Stabilizers
Parenteral
Topical
Taste Masking
Coating Systems & Additives
Controlled & Modified Release
Emulsifying Agents
Fillers, Diluents & Binders
Direct Compression
Granulation
Surfactant & Foaming Agents
Co-Processed Excipients
Chewable & Orodispersible Aids
API Stability Enhancers
Soft Gelatin
Rheology Modifiers
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
36
PharmaCompass offers a list of UNII-B7XF2TD73C API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right UNII-B7XF2TD73C manufacturer or UNII-B7XF2TD73C supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred UNII-B7XF2TD73C manufacturer or UNII-B7XF2TD73C supplier.
PharmaCompass also assists you with knowing the UNII-B7XF2TD73C API Price utilized in the formulation of products. UNII-B7XF2TD73C API Price is not always fixed or binding as the UNII-B7XF2TD73C Price is obtained through a variety of data sources. The UNII-B7XF2TD73C Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nevirapine hemihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nevirapine hemihydrate, including repackagers and relabelers. The FDA regulates Nevirapine hemihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nevirapine hemihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nevirapine hemihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nevirapine hemihydrate supplier is an individual or a company that provides Nevirapine hemihydrate active pharmaceutical ingredient (API) or Nevirapine hemihydrate finished formulations upon request. The Nevirapine hemihydrate suppliers may include Nevirapine hemihydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Nevirapine hemihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nevirapine hemihydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Nevirapine hemihydrate active pharmaceutical ingredient (API) in detail. Different forms of Nevirapine hemihydrate DMFs exist exist since differing nations have different regulations, such as Nevirapine hemihydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Nevirapine hemihydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Nevirapine hemihydrate USDMF includes data on Nevirapine hemihydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nevirapine hemihydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Nevirapine hemihydrate suppliers with USDMF on PharmaCompass.
A Nevirapine hemihydrate written confirmation (Nevirapine hemihydrate WC) is an official document issued by a regulatory agency to a Nevirapine hemihydrate manufacturer, verifying that the manufacturing facility of a Nevirapine hemihydrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Nevirapine hemihydrate APIs or Nevirapine hemihydrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Nevirapine hemihydrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Nevirapine hemihydrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nevirapine hemihydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nevirapine hemihydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nevirapine hemihydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nevirapine hemihydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nevirapine hemihydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nevirapine hemihydrate suppliers with NDC on PharmaCompass.
Nevirapine hemihydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nevirapine hemihydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nevirapine hemihydrate GMP manufacturer or Nevirapine hemihydrate GMP API supplier for your needs.
A Nevirapine hemihydrate CoA (Certificate of Analysis) is a formal document that attests to Nevirapine hemihydrate's compliance with Nevirapine hemihydrate specifications and serves as a tool for batch-level quality control.
Nevirapine hemihydrate CoA mostly includes findings from lab analyses of a specific batch. For each Nevirapine hemihydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nevirapine hemihydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Nevirapine hemihydrate EP), Nevirapine hemihydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nevirapine hemihydrate USP).
